EPM2AIP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.629400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.956400E-01
Normal-vs-Stage2
3.372800E-01
Normal-vs-Stage3
2.053800E-01
Normal-vs-Stage4
4.390600E-01
Stage1-vs-Stage2
2.027800E-01
Stage1-vs-Stage3
5.258400E-02
Stage1-vs-Stage4
6.662600E-01
Stage2-vs-Stage3
6.00600000000284E-05
Stage2-vs-Stage4
1.158380E-01
Stage3-vs-Stage4
3.243800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.699000E-01
Normal-vs-AfricanAmerican
1.292970E-01
Normal-vs-Asian
5.478000E-02
Caucasian-vs-AfricanAmerican
6.710000E-01
Caucasian-vs-Asian
3.665200E-01
AfricanAmerican-vs-Asian
8.208200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.510000E-01
Normal-vs-Female
3.810000E-01
Male-vs-Female
4.372000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.590200E-01
Normal-vs-Age(41-60Yrs)
4.061600E-01
Normal-vs-Age(61-80Yrs)
3.445200E-01
Normal-vs-Age(81-100Yrs)
2.865800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.228800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.564400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.944000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.414650E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.957600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.398600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.344400E-01
Normal-vs-Daily Drinker
3.160200E-01
Normal-vs-Weekly Drinker
2.948800E-01
Normal-vs-Occasional Drinker
3.673400E-01
Normal-vs-Social Drinker
1.957800E-01
Non Drinker-vs-Daily Drinker
7.146000E-01
Non Drinker-vs-Weekly Drinker
4.653600E-01
Non Drinker-vs-Occasional Drinker
6.406200E-01
Non Drinker-vs-Social Drinker
9.591700E-02
Daily Drinker-vs-Weekly Drinker
6.876800E-01
Daily Drinker-vs-Occasional Drinker
4.528400E-01
Daily Drinker-vs-Social Drinker
6.741800E-02
Weekly Drinker-vs-Occasional Drinker
3.097600E-01
Weekly Drinker-vs-Social Drinker
5.773800E-02
Occasional Drinker-vs-Social Drinker
2.910400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.549820E-01
Normal-vs-Grade 2
2.606100E-02
Normal-vs-Grade 3
1.527980E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.140800E-01
Grade 1-vs-Grade 3
2.924000E-01
Grade 1-vs-Grade 4
1.549820E-01
Grade 2-vs-Grade 3
7.151800E-01
Grade 2-vs-Grade 4
2.606100E-02
Grade 3-vs-Grade 4
1.527980E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.060000E-01
Normal-vs-NonDiabetic
3.622600E-01
Diabetic-vs-NonDiabetic
9.182300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.133200E-01
Normal-vs-NoPancreatitis
3.522600E-01
Pancreatitis-vs-NoPancreatitis
3.032400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.091400E-01
Normal-vs-N1
3.365200E-01
N0-vs-N1
1.010640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.792000E-01
Normal-vs-TP53-NonMutant
5.405000E-01
TP53-Mutant-vs-TP53-NonMutant
1.119770E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
